Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer

A retrospective cohort study of 471 patients with head and neck cancer treated with definitive, curative-intent radiotherapy found that those who attended a multidisciplinary survivorship clinic before finishing treatment had significantly better outcomes. Among the participants, 148 patients, or 31.4 percent, received early survivorship care. These patients had 55 percent lower odds of not following their radiotherapy schedule compared to those who did not attend the clinic. The study also reported a lower three-year recurrence risk for the early care group, with a subdistribution hazard ratio of 0.62, and improved three-year disease-free survival with a hazard ratio of 0.61. The associations remained significant after researchers adjusted the analysis for clinical factors such as tumor stage and nodal status, as well as sociodemographic variables including insurance status, tobacco and alcohol use, and neighborhood socioeconomic disadvantage. Importantly, the survival benefit was not explained solely by differences in treatment adherence, suggesting that early survivorship care influences outcomes through additional pathways beyond completing radiotherapy. The study design was single center and retrospective, which limits the ability to draw causal conclusions or generalize the findings to other settings. Investigators noted that the specific components of care responsible for the observed benefits were not identified, and they plan future work to evaluate health care utilization and costs, as well as to conduct a randomized controlled trial to better isolate the effects of early intervention.